DAM
OACCU

DLD Asset Management’s Oaktree Acquisition Corp III Life Sciences Unit OACCU Stock Holding History

DLD Asset Management’s Portfolio OACCU Stock Details OACCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-44,519
Closed -$33.4K – 481
2026
Q1 		$33.4K Buy
+44,519
New +$477K ﹤0.01% 272

Other funds holding OACCU

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DLD Asset Management's OACCU Position: Q2 2026 in Review

DLD Asset Management sold out of Oaktree Acquisition Corp III Life Sciences Unit (OACCU) in Q2 2026, closing a stake of 44,519 shares — an estimated $33.4K sold.

DLD Asset Management first reported a position in OACCU in Q1 2026 and held it in 1 quarter. The position peaked at $33.4K in Q1 2026. 5 funds tracked by Wall St. Rank hold OACCU as of Q2 2026.

  • DLD Asset Management reported no remaining Oaktree Acquisition Corp III Life Sciences Unit position as of Q2 2026 after selling out during the quarter.
  • DLD Asset Management sold 44,519 Oaktree Acquisition Corp III Life Sciences Unit shares in Q2 2026, an estimated $33.4K.
  • DLD Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences Unit in Q1 2026 and held it in 1 quarter.
  • DLD Asset Management's Oaktree Acquisition Corp III Life Sciences Unit position peaked at $33.4K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Unit as of Q2 2026.

Based on DLD Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.